Coya Therapeutics, Inc. Common Stock (COYA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $73.42M
Last updated: Nov 17, 2026 at 11:04 AM ET
Coya Therapeutics, Inc. Common Stock (COYA) Competitors
The companies most similar to Coya Therapeutics, Inc. Common Stock are Tenaya Therapeutics (TNYA), Cognition Therapeutics (CGTX) and Corbus Pharmaceuticals Holding (CRBP). By market cap, Coya Therapeutics, Inc. Common Stock ranks 6th of the 13 companies on this page; OUTLOOK THERAPEUTICS INC (OTLK) is the largest at $100.54M.
Peer Comparison
COYA's revenue growth of -93.4% is below the peer median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Coya Therapeutics, Inc. Common Stock (COYA) | $73.42M | N/A | 15.0x | 0.0% | N/A | -93.4% | 0.00% |
| Tenaya Therapeutics Inc (TNYA) | $79.59M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Cognition Therapeutics Inc (CGTX) | $64.65M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Corbus Pharmaceuticals Holding (CRBP) | $69.86M | N/A | 13.9x | 0.0% | -106.7% | -100.0% | 0.00% |
| Coherus BioSciences Inc (CHRS) | $81.21M | N/A | 1.5x | -253.4% | -144.8% | 23.4% | 0.00% |
| OKYO Pharma Limited (OKYO) | $70.85M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| OUTLOOK THERAPEUTICS INC (OTLK) | $100.54M | N/A | N/A | 0.0% | -776.9% | -99.4% | 0.00% |
| Oncolytics Biotech Inc (ONCY) | $48.51M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| vTv Therapeutics Inc (VTVT) | $78.99M | N/A | N/A | -20.8% | N/A | 0.0% | 0.00% |
| Tenax Therapeutics Inc (TENX) | $73.77M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Gain Therapeutics Inc (GANX) | $46.31M | N/A | N/A | 0.0% | -170.5% | -100.0% | 0.00% |
| Tiziana Life Sciences Ltd (TLSA) | $72.53M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Cardiff Oncology Inc (CRDF) | $56.49M | N/A | 115.5x | 0.0% | N/A | -14.1% | 0.00% |
| Peer median | $71.69M | N/A | 13.9x | 0.0% | -157.6% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Coya Therapeutics, Inc. Common Stock, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Tenaya Therapeutics Inc (TNYA) | Tenaya Therapeutics Inc. is a pioneering clinical-stage biotechnology firm that is revolutionizing the treatment of heart disease through its proprietary... | TNYA competitors |
| Cognition Therapeutics Inc (CGTX) | Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of small molecule therapies targeting... | CGTX competitors |
| Corbus Pharmaceuticals Holding (CRBP) | Corbus Pharmaceuticals Holdings, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of novel therapies that target... | CRBP competitors |
| Coherus BioSciences Inc (CHRS) | Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilars and immuno-oncology market primarily in the United States. | CHRS competitors |
| OKYO Pharma Limited (OKYO) | OKYO Pharma Limited, a preclinical biopharmaceutical company, is engaged in developing therapies for patients suffering from inflammatory eye diseases and eye... | |
| OUTLOOK THERAPEUTICS INC (OTLK) | Outlook Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic... | OTLK competitors |
| Oncolytics Biotech Inc (ONCY) | Oncolytics Biotech Inc., a developing-stage biopharmaceutical company, focuses on the discovery and development of pharmaceuticals for the treatment of cancer. | ONCY competitors |
| vTv Therapeutics Inc (VTVT) | vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers, develops and sells candidates for orally administered small molecule drugs to meet... | VTVT competitors |
| Tenax Therapeutics Inc (TENX) | Tenax Therapeutics, Inc., a specialty pharmaceutical company, is dedicated to identifying, developing... | TENX competitors |
| Gain Therapeutics Inc (GANX) | Gain Therapeutics, Inc., a developing biotechnology company, is dedicated to developing a variety of therapies to treat diseases caused by protein misfolding. | GANX competitors |
| Tiziana Life Sciences Ltd (TLSA) | Tiziana Life Sciences Plc, a clinical-stage biotechnology company, focuses on the discovery and development of molecules and related diagnostics to treat... | |
| Cardiff Oncology Inc (CRDF) | Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops drugs for the treatment of cancer. | CRDF competitors |
Frequently Asked Questions About COYA
Who are Coya Therapeutics, Inc. Common Stock's main competitors?
The companies most similar to Coya Therapeutics, Inc. Common Stock include Tenaya Therapeutics (TNYA), Cognition Therapeutics (CGTX), Corbus Pharmaceuticals Holding (CRBP), Coherus BioSciences (CHRS) and OKYO Pharma (OKYO), listed from the closest match.
Who is Coya Therapeutics, Inc. Common Stock's biggest competitor?
OUTLOOK THERAPEUTICS INC (OTLK) is the largest of the similar companies at $100.54M; Tenaya Therapeutics (TNYA) is the closest match by business profile, size, sector and industry.
How does COYA stock compare with its competitors?
COYA's P/S is 15.0x against a peer median of 13.9x; its net margin is 0.0% against a peer median of 0.0%.
Which of Coya Therapeutics, Inc. Common Stock's competitors pays a higher dividend?
Coya Therapeutics, Inc. Common Stock pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Coya Therapeutics, Inc. Common Stock bigger than its competitors?
No. Coya Therapeutics, Inc. Common Stock is 6th by market cap among the 13 companies on this page; the largest is OUTLOOK THERAPEUTICS INC (OTLK) at $100.54M.
COYA pages: Overview, Earnings, Forecast, Financials, Competitors